Antiviral medication to reduce symptoms of COVID-19: A phase 3, placebo-controlled trial
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: COVID-19
-
Age: Between 18 - 64 Years
-
Gender: Male or Female